These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32330518)

  • 1. Progressive brain changes in Parkinson's disease: A meta-analysis of structural magnetic resonance imaging studies.
    He H; Liang L; Tang T; Luo J; Wang Y; Cui H
    Brain Res; 2020 Aug; 1740():146847. PubMed ID: 32330518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild cognitive impairment in Parkinson's disease is associated with decreased P300 amplitude and reduced putamen volume.
    Hünerli D; Emek-Savaş DD; Çavuşoğlu B; Dönmez Çolakoğlu B; Ada E; Yener GG
    Clin Neurophysiol; 2019 Aug; 130(8):1208-1217. PubMed ID: 31163365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional volumetric change in Parkinson's disease with cognitive decline.
    Gee M; Dukart J; Draganski B; Wayne Martin WR; Emery D; Camicioli R
    J Neurol Sci; 2017 Feb; 373():88-94. PubMed ID: 28131236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural brain correlates of fatigue in older adults with and without Parkinson's disease.
    Kluger BM; Zhao Q; Tanner JJ; Schwab NA; Levy SA; Burke SE; Huang H; Ding M; Price C
    Neuroimage Clin; 2019; 22():101730. PubMed ID: 30818269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease.
    Xu Y; Yang J; Hu X; Shang H
    J Neurol; 2016 Jun; 263(6):1178-87. PubMed ID: 27113603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
    Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grey matter abnormalities in Parkinson's disease: a voxel-wise meta-analysis.
    Xu X; Han Q; Lin J; Wang L; Wu F; Shang H
    Eur J Neurol; 2020 Apr; 27(4):653-659. PubMed ID: 31770481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical thinning across Parkinson's disease stages and clinical correlates.
    Wilson H; Niccolini F; Pellicano C; Politis M
    J Neurol Sci; 2019 Mar; 398():31-38. PubMed ID: 30682518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature.
    Sarasso E; Agosta F; Piramide N; Filippi M
    J Neurol; 2021 Sep; 268(9):3144-3179. PubMed ID: 32378035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voxelwise meta-analysis of gray matter anomalies in Parkinson variant of multiple system atrophy and Parkinson's disease using anatomic likelihood estimation.
    Shao N; Yang J; Shang H
    Neurosci Lett; 2015 Feb; 587():79-86. PubMed ID: 25484255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies.
    Olabi B; Ellison-Wright I; McIntosh AM; Wood SJ; Bullmore E; Lawrie SM
    Biol Psychiatry; 2011 Jul; 70(1):88-96. PubMed ID: 21457946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voxel-wise meta-analysis of structural changes in gray matter of Parkinson's disease patients with mild cognitive impairment.
    Qin B; Yang MX; Gao W; Zhang JD; Zhao LB; Qin HX; Chen H
    Braz J Med Biol Res; 2020; 53(6):e9275. PubMed ID: 32428131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.
    Almeida OP; Burton EJ; McKeith I; Gholkar A; Burn D; O'Brien JT
    Dement Geriatr Cogn Disord; 2003; 16(2):57-63. PubMed ID: 12784028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
    Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
    J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls.
    Jakimovski D; Bergsland N; Dwyer MG; Hagemeier J; Ramasamy DP; Szigeti K; Guttuso T; Lichter D; Hojnacki D; Weinstock-Guttman B; Benedict RHB; Zivadinov R
    Neurobiol Aging; 2020 Jun; 90():84-92. PubMed ID: 32147244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal and subcortical contribution to visual hallucinations in dementia with Lewy bodies and Parkinson's disease.
    Pezzoli S; Cagnin A; Antonini A; Venneri A
    Postgrad Med; 2019 Sep; 131(7):509-522. PubMed ID: 31422718
    [No Abstract]   [Full Text] [Related]  

  • 17. Longitudinal Study of Gray Matter Changes in Parkinson Disease.
    Jia X; Liang P; Li Y; Shi L; Wang D; Li K
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2219-26. PubMed ID: 26359153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional gray matter reductions associated with mild cognitive impairment in Parkinson's disease: A meta-analysis of voxel-based morphometry studies.
    Zheng D; Chen C; Song W; Yi Z; Zhao P; Zhong J; Dai Z; Shi H; Pan P
    Behav Brain Res; 2019 Oct; 371():111973. PubMed ID: 31128163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment.
    Uchida Y; Kan H; Sakurai K; Arai N; Kato D; Kawashima S; Ueki Y; Matsukawa N
    Mov Disord; 2019 Aug; 34(8):1164-1173. PubMed ID: 31091347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.